生物制药公司Atossa Genetics Inc宣布,已签署一项市场发售协议,计划通过出售公司普通股筹集最高5000万美元资金。该融资安排将根据市场条件适时推进,旨在为公司在乳腺癌治疗领域的新药研发项目提供资金支持。
生物制药公司Atossa Genetics Inc宣布,已签署一项市场发售协议,计划通过出售公司普通股筹集最高5000万美元资金。该融资安排将根据市场条件适时推进,旨在为公司在乳腺癌治疗领域的新药研发项目提供资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.